BROSHY ERAN 4
4 · Theravance Biopharma, Inc. · Filed May 10, 2024
Insider Transaction Report
Form 4
BROSHY ERAN
Director
Transactions
- Award
Share Option (Right to Buy)
2024-05-08+23,576→ 23,576 totalExercise: $9.49Exp: 2034-05-07→ Ordinary Shares (23,576 underlying) - Award
Ordinary Shares
2024-05-08+10,537→ 80,555 total
Footnotes (1)
- [F1]This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.